Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dawmed Sys | LSE:DSY | London | Ordinary Share | GB0030032881 | ORD 5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.00 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 5.00 | GBX |
Dawmed Systems (DSY) Share Charts1 Year Dawmed Systems Chart |
|
1 Month Dawmed Systems Chart |
Intraday Dawmed Systems Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 27/8/2015 | 21:51 | hospital disinfector machines - SARS driven? | 15 |
| 22/7/2009 | 13:54 | Dawmed results out | 206 |
| 06/7/2009 | 14:20 | Takeover Price | 10 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 06/7/2009 11:50 by freestyle "Following the sale of DIL, DMS will become an investing company for AIM Rules purposes and its proposed investing policy will require approval by shareholders of DMS. Following completion of the Sale the Continuing Directors, being Kevin Gilmore, Gordon Arbib and Nicholas Trigg, propose that, instead of winding up the Company, the Company's share capital should remain admitted to trading on AIM and that the Company's New Investing Policy should be based predominantly upon the acquisition for and development of and/or investment in commercial property, commercial property agency and the acquisition of land for and development of high end residential property, together with potential corporate acquisitions, the latter mainly in the property sector." So from washer disinfectors to property company, no wonder the market has reacted as such to this! Best of luck with this move, the market is at a bottom, but I just can't see how a management company which had been higly focussed and qualified in a niche sector can switch and sart making decisions about property acquistion. I think DIL will be wound up in 12-24 months time afetr all the cash has been spent. Wonder how barclays with their holding feel about this one or if they have advised this move. |
Posted at 05/7/2009 20:07 by gelp Sale of Operating Subsidiary (Dawmed Systems)TIDMDSY RNS Number : 1325V DawMed Systems PLC 03 July 2009 ? For Immediate Release 3 July 2009 DawMed Systems plc ("Company") Sale of Operating Subsidiary DawMed Systems plc ("DMS") announces that it has today signed a conditional agreement with Wassenburg & Co B.V. ("Wassenburg") for the sale of all the issued share capital in DawMed International Limited ("DIL"), DMS' sole operating subsidiary. The consideration for the sale is the sum of GBP950,000 in cash (to be paid on completion). Completion accounts will be drawn up as at 1 July 2009 and there will be an adjustment to the consideration on the basis of DIL's net assets being more or less than GBP75,000. DMS and Wassenburg will each share 50% of any such shortfall in or excess of net assets. Whilst the Directors believe that the Second Interim Results were relatively satisfactory and pointed to an anticipated continuation of growth up to the period ended 31 March 2009, the Board considers that there are fundamental reasons why the present business does not provide a long-term basis for the Company's future viability as an independent entity. The Company is largely reliant upon its distribution agreement with Wassenburg for its imported equipment and the vagaries of the Sterling/Euro currency exchange rates mean that any profit margin on sales can be easily wiped out by a small change in the exchange rates. The sale of DIL is subject, inter alia, to the consent of shareholders of DMS. Conditional upon the completion of the sale of DIL, John Crispin and Mark Adamson will cease to be directors of DMS, but will continue as directors of DIL. The Directors of DMS believe that, having explored other sales opportunities, the sale of DIL at the above price is the best return that can be expected. Following the sale, the Company will be an investing company with net cash resources of approximately GBP800,000 being the proceeds of the sale, which, together with available bank finance will be utilised for the proposed investing policy. In the 18 months to 31 March 2009, DIL reported an audited loss on ordinary activities before taxation of GBP473,410 (year ended 30 September 2007: GBP571,508) on a turnover of GBP12,209,849 (year ended 30 September 2007: GBP4,976,158). During this period, DIL issued 2,184,500 new shares at par to the Company to strengthen its balance sheet. At 31 March 2009, DIL had net assets of GBP83,870 (30 September 2007 net liabilities: GBP1,627,220). A more detailed explanation of the trading performance of DIL will be provided in the circular to shareholders referred to below. Following the sale of DIL, DMS will become an investing company for AIM Rules purposes and its proposed investing policy will require approval by shareholders of DMS. Following completion of the Sale the Continuing Directors, being Kevin Gilmore, Gordon Arbib and Nicholas Trigg, propose that, instead of winding up the Company, the Company's share capital should remain admitted to trading on AIM and that the Company's New Investing Policy should be based predominantly upon the acquisition for and development of and/or investment in commercial property, commercial property agency and the acquisition of land for and development of high end residential property, together with potential corporate acquisitions, the latter mainly in the property sector. A circular will be despatched to DMS shareholders as soon as reasonably practicable, which will provide further details of the sale and the reasons for the sale, and convening two general meetings, the first to approve the sale of DIL and the DMS' proposed investing policies under the AIM Rules (which will be ordinary resolutions) and the second to approve the change of name of DMS (which will be a special resolution). 3 July 2009 Enquiries: Kevin Gilmore Chairman DawMed Systems plc01608 682244 Roland Cornish Chairman Beaumont Cornish Limited 020 7628 3396 This information is provided by RNS The company news service from the London Stock Exchange END DISBLGDRGBGGGCX |
Posted at 20/5/2009 14:43 by freestyle OK chaps,Pure speculation thread. I've held these since first listing be intertested to hear of your thoughts for price to be paid for the company and how it will be paid should the approach turn into a takeover. My thoughts are: Market cap of the company £5-6M, paid for cash.approx 25-30p per share Be interesting to see how much the intangibles will be costed at, patents, brands etc. |
Posted at 18/5/2009 09:05 by jambo172 Hope they don't give it away at a cheap price.Turnover >£7m, profitable and good order book. Please be greedy on price! |
Posted at 16/5/2009 12:30 by devbod Takeover approach! Announced after market close last night. Now if its over 22p a share I might break even ;) |
Posted at 28/2/2009 09:14 by mjcrockett Agree with you there, Gelp. I notice that Dawmed, like many other tiny AIM companies, is running out of Market Makers. A year ago they had 4 market makers covering the stock but today Winterfloods is the only one. This does lead to a wider spread and tends to increase volatility with the price moving a lot on low volume. MJ |
Posted at 28/2/2009 09:08 by gelp Not hard to see why the the share is being rerated - the interim report clearly showed optimism & recovery improgress & profit forcast - but no body either read it or believed it as was so long coming!I think we misread the accounting date change as a negative and assumed 12 month figures would be depressed - looks like there was no ulterior motive at all. The price just continually drifted down & accellerated due to the market conditions. In spite of the banks efforts to drag every one else down life does go on & I guess that a combination of long experience and close supplier support and determination plus perhaps a liitle luck (the harder you work the luckier you get..!) have enable a genuine improvement on all fronts. The lows in price were never really available in any numbers (the tripling has to be viewed in context) & i guess those in similar markets will be viewing the lowly valuation with interest as will the directors if the price does not seriously respond to the better news. Well done Directors for keeping the news really quiet - no leakages! |
Posted at 26/2/2009 10:43 by gelp Nothing whatsoever like TWL.Historically DSY has disappointed and forex rubbed salt in wounds. DSY is well established and interesting balance with own making and brand representation. The area of business is well known and no lack of demand. Well motivated & very experienced board & blue chip debtors. The statement for once is not defensive and I think if anything is restrained. The numbers and portfoloio of products speak for themselves. DSY listed on ofex originally at 10 million and this morning m/c was under 500k. Sales are 7.4 million for the 12 months, growing and now with a profit. Indications are for a continuation of the progress made and if the next three months figures follow the pattern then has to be target for bigger group or maker or MBO if frustration with price. Pleased to see costs down as well as sales up. |
Posted at 04/12/2008 16:27 by mjcrockett Red letter day today! A post on the bulletin board AND the share price goes up.I guess that we will see results this month. MJ |
Posted at 28/4/2008 13:14 by mjcrockett The funny thing is that on Friday with the price quoted at 4.00/6.00 the actual price quoted to buy was 4.74p. Today, with the price quoted at 3.50/5.50, the buy price is 5.00p. Movements in the share price such as we are seeing now are purely marketmaker games.I went to the Dawmed AGM on Friday. I think the AGM statement covers most of what was discussed. The company is seemingly recovering well from a bad year last year and the prospects look reasonably bright. In my view, the share price does not yet reflect the change in fortunes. MJ |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
